Identification of approved drugs that inhibit the binding of amyloid ß oligomers to ephrin type-B receptor 2.

Suzuki, Koichiro; Aimi, Takahiro; Ishihara, Tomoaki; Mizushima, Tohru

Suzuki, Koichiro; Aimi, Takahiro; Ishihara, Tomoaki; Mizushima, Tohru.

Afiliación

Suzuki K; Division of Drug Discovery and Development Faculty of Pharmacy Keio University Minato-ku Tokyo Japan; Research Fellow of Japan Society for the Promotion of Science Chiyoda-ku Tokyo Japan.
Aimi T; Division of Drug Discovery and Development Faculty of Pharmacy Keio University Minato-ku Tokyo Japan.
Ishihara T; Division of Drug Discovery and Development Faculty of Pharmacy Keio University Minato-ku Tokyo Japan.
Mizushima T; LTT Bio-Pharma Co., Ltd Minato-ku Tokyo Japan.

FEBS Open Bio ; 6(5): 461-8, 2016 05.

Article en En | MEDLINE | ID: mdl-27419051

Palabras clave

Alzheimer's disease; amyloid ß oligomer; ephrin typeB receptor 2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: FEBS Open Bio Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google